Lv21
130 积分 2024-12-11 加入
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
6小时前
已完结
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
1个月前
已完结
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides
2个月前
已完结
Phase I Study of the Sequential Combination of Interleukin-12 and Interferon Alfa-2b in Advanced Cancer: Evidence for Modulation of Interferon Signaling Pathways by Interleukin-12
2个月前
已关闭
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
5个月前
已完结
Analyzing the Tumor-Immune Microenvironment by Flow Cytometry
5个月前
已完结
Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapy
6个月前
已完结
Ablation of FAS confers allogeneic CD3– CAR T cells with resistance to rejection by T cells and natural killer cells
7个月前
已完结
A tumor-conditional IL-15 safely synergizes with immunotherapy to enhance antitumor immune responses
11个月前
已完结
皖公网安备34019202002308
